Currently, chemotherapy remains a common treatment for biliary tract cancers, which have a limited survival rate.

GlobeNewswire, Health, Pharmaceuticals & Biotechnology, Product / Services Announcement | Ziihera is the first and only dual HER2-targeted bispecific ...

Researchers estimate vaccines for enteric pathogens could prevent up to 8 to 12 courses of antibiotics per 100 vaccinated ...

Miplyffa was approved in September 2024 based on data from a clinical trial that showed arimoclomol plus miglustat slowed NPC disease progression.

diarrhea and stomach cramps – are also common with other foodborne illnesses, so it can be difficult to tell if you have an E ...

The cumulative incidence of depression was higher among those with migraine during fall 2020 (15%) than in those without (12%).

Grimmway Farms has recalled its organic carrots after health officials linked them to an E. coli outbreak. A woman who was ...

With yet another food recalled due to E. coli contamination, a New York doctor shared information about how people can best stay protected from the bacteria.

When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals' drug, zanidatamab-hrii, for the treatment of a type of ...